The inflammatory cytokine IFN-γ is known to trigger the upregulation of PD-L1, while recent literature suggests that oncogenic signals such as RAS mutation,17 MYC18, and MLL119 also promote PD-L1 expression in cancer cells. This evidence concerns the gene CD274 and cancer.